Skip to content

Clinical trials

Basal Cell Carcinoma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Basal Cell Carcinoma Country / region: Australia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20052
20092
20112
20131
20192
20201
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Galderma R&D2
Melanoma Institute Australia2
Novartis Pharmaceuticals2
Peplin2
Regeneron Pharmaceuticals2
Ascend Biopharmaceuticals Ltd1
Blaze Bioscience Australia Pty Ltd1
Genentech, Inc.1
Hoffmann-La Roche1
Medicenna Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Basal Cell Carcinoma15
Cutaneous Squamous Cell Carcinoma4
Skin Neoplasms4
Carcinoma, Merkel Cell3
Melanoma3
Neoplasm Metastasis2
Squamous Cell Carcinoma of Head and Neck2
Triple Negative Breast Neoplasms2
Basal Cell Nevus Syndrome1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.